Benedicte Brounais-Le Royer
Overview
Explore the profile of Benedicte Brounais-Le Royer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dupuy M, Postec A, Mullard M, Chantome A, Hulin P, Brion R, et al.
Cell Commun Signal
. 2024 Dec;
22(1):602.
PMID: 39695664
Background: Ewing sarcoma (ES), the second main pediatric bone sarcoma, is characterised by a chromosomal translocation leading to the formation of fusion proteins like EWS::FLI1. While several studies have shown...
2.
Dupuy M, Gueguinou M, Postec A, Brion R, Tesfaye R, Mullard M, et al.
Oncogene
. 2024 Nov;
44(2):79-91.
PMID: 39487324
Ewing sarcoma (ES) is characterized by EWS::FLI1 or EWS::ERG fusion proteins. Knowing that ion channels are involved in tumorigenesis, this work aimed to study the involvement of the KCNN1 gene,...
3.
Dupuy M, Lamoureux F, Mullard M, Postec A, Regnier L, Baudhuin M, et al.
Front Cell Dev Biol
. 2023 Sep;
11:1248753.
PMID: 37752913
In Europe, with an incidence of 7.5 cases per million, Ewing sarcoma (ES) is the second most common primary malignant bone tumor in children, adolescents and young adults, after osteosarcoma....
4.
Tesfaye R, Lavaud M, Charrier C, Brounais-Le Royer B, Cartron P, Verrecchia F, et al.
Environ Health Perspect
. 2023 Jun;
131(6):67007.
PMID: 37307168
Background: Osteoclasts are major actors in the maintenance of bone homeostasis. The full functional maturation of osteoclasts from monocyte lineage cells is essential for the degradation of old/damaged bone matrix....
5.
Brion R, Gantier M, Biteau K, Taurelle J, Brounais-Le Royer B, Verrecchia F, et al.
Cancers (Basel)
. 2022 Nov;
14(22).
PMID: 36428719
Despite advances in clinical management, osteosarcoma and Ewing sarcoma, the two most frequent malignant primary bone tumors at pediatric age, still have a poor prognosis for high-risk patients (i.e., relapsed...
6.
Munoz-Garcia J, William Vargas-Franco J, Brounais-Le Royer B, Cochonneau D, Amiaud J, Heymann M, et al.
Cancers (Basel)
. 2022 Apr;
14(7).
PMID: 35406536
Current treatments for osteosarcoma, combining conventional polychemotherapy and surgery, make it possible to attain a five-year survival rate of 70% in affected individuals. The presence of chemoresistance and metastases significantly...
7.
Morice S, Danieau G, Tesfaye R, Mullard M, Brion R, Dupuy M, et al.
Front Oncol
. 2021 Nov;
11:765711.
PMID: 34765560
Background: The poor survival rate of patients with osteosarcoma (OS), specifically with metastases at diagnosis, undergoes the urgency to develop new therapeutic strategies. Although we recently demonstrated the key role...
8.
Lavaud M, Mullard M, Tesfaye R, Amiaud J, Legrand M, Danieau G, et al.
Cells
. 2021 Sep;
10(9).
PMID: 34571917
Osteosarcoma (OS) is the most common malignant bone tumor in children and teenagers. In many cases, such as poor response to treatment or the presence of metastases at diagnosis, the...
9.
Danieau G, Morice S, Renault S, Brion R, Biteau K, Amiaud J, et al.
Pharmaceuticals (Basel)
. 2021 Jun;
14(5).
PMID: 34062831
High-grade osteosarcomas are the most frequent malignant bone tumors in the pediatric population, with 150 patients diagnosed every year in France. Osteosarcomas are associated with low survival rates for high...
10.
Morice S, Mullard M, Brion R, Dupuy M, Renault S, Tesfaye R, et al.
Cancers (Basel)
. 2021 Jan;
12(12).
PMID: 33419295
Although some studies suggested that disruption of the Hippo signaling pathway is associated with osteosarcoma progression, the molecular mechanisms by which YAP regulates primary tumor growth is not fully clarified....